van der Vijver-Coppen Rozemarijn J, 't Mannetje Yannick W, Menting Theo P, Lardenoije Jan-Willem, Reijnen Michel P
Department of Vascular Sugery, Rijnstate Hospital, Arnhem, The Netherlands -
Department of Vascular Sugery, Rijnstate Hospital, Arnhem, The Netherlands.
J Cardiovasc Surg (Torino). 2018 Apr;59(2):158-163. doi: 10.23736/S0021-9509.18.10374-0. Epub 2018 Jan 9.
Peripheral artery disease affects 202 million patients worldwide and may cause disabling intermittent claudication and critical limb ischemia. Next to life style changes, best medical treatment and supervised exercise therapy, it can be necessary to re-vascularize the limb. Treatment of femoropopliteal lesions poses a challenge and a surgical bypass remains recommended in the guidelines for longer and more complex lesions. Bypass surgery is associated with substantial morbidity and even mortality. Endovascular alternatives are quickly evolving from plain balloon angioplasty to drug-eluting stents, drug-coated balloons, polytetrafluoroethylene-covered stents and atherectomy. These developments might challenge the gold standard in the near future. This article focuses on which technique can be used for which femoropopliteal lesion, particularly complex lesions, and summarizes the most recent and important literature on this topic.
